CLRO SCHEDULE 13D/A: Activist campaign

First Finance Ltd. and Andrew Hromyk

Filed with the SEC on · accession 0001493152-26-052955

CLRO filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 17, 2026. First Finance Ltd. and Andrew Hromyk filed an amended Schedule 13D reporting beneficial ownership of approximately 58.3% of ClearOne Inc. after acquiring 499,999 shares through a private placement and debt conversion. The stock moved -1.3% by the first close after the filing.

Summary of the filing

First Finance Ltd. and Andrew Hromyk filed an amended Schedule 13D reporting beneficial ownership of approximately 58.3% of ClearOne Inc. after acquiring 499,999 shares through a private placement and debt conversion. The filing states the reporting persons are supportive of the pending merger with Cortigent and have no plans to change control or strategy.

Key details

Private placement subscription price for 188,885 shares$756K
Debt converted into 311,114 shares$1.2M
Total private placement gross consideration including loan conversion$4.0M
Total shares acquired in private placement and debt conversion$500K
Reporting person / majority beneficial ownerFirst Finance Ltd.
IssuerClearOne, Inc.
Merger targetCortigent, Inc.
Parent of cortigentVivani Medical, Inc.
Control person of first finance ltd.Andrew Hromyk

How CLRO stock reacted

Close before

$4.78

Nov 16, 2026

First close after

-1.26%

$4.72

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CLRO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CLRO?

Click here

Frequently asked questions

What did CLRO file with the SEC on Nov 17, 2026?

CLRO filed a SCHEDULE 13D/A (Activist campaign). First Finance Ltd. and Andrew Hromyk filed an amended Schedule 13D reporting beneficial ownership of approximately 58.3% of ClearOne Inc. after acquiring 499,999 shares through a private placement and debt conversion. The filing states the reporting persons are supportive of the pending merger with Cortigent and have no plans to change control or strategy.

What does a activist campaign mean for CLRO stock?

A settlement removes uncertainty; the stock often reacts to whether the amount is bigger or smaller than investors expected.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did CLRO stock react to this filing?

CLRO closed at $4.78 before the filing and $4.72 on Nov 17, 2026 (-1.26%).

Other CLRO SEC filings

Get alerts when CLRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days